chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Malaise, Vaccination site pain, Vaccination site pruritus, Vaccination site rash, Vaccination site swelling
Clinical narrative: Not feeling well; Arm started to hurt/arm tender to the touch; Site a little bit raised; Arm started getting itchy; Arm still hot, it was hot to touch; Rash on the injection site; A spontaneous report was received from a consumer concerning a 70-year old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced arm started to hurt, arm tender to the touch (vaccination site pain), site a little bit raised (vaccination site swelling), arm started getting itchy (vaccination site pruritus), arm still hot (vaccination site warmth), rash on injection site (vaccination site rash) and not feeling well (malaise).  The patient's medical history was not provided. Concomitant medications were omeprazole, levothyroxine, lovastatin, carvedilol and aspirin.  On 9 Feb 2021, the patient received their first of two planned doses of mRNA-1273 (Batch number: unknown) for the prophylaxis of COVID-19 infection.  Patient received the vaccine on 09 Feb 2021 and her arm started to hurt was a little bit raised and tender to the touch. Later that night it started to get itchy. Patient stated arm was hot and tender.  Treatment information mentioned says took Tylenol PM and Benadryl. Lab tests not provided.  Action taken with response to mRNA-1273 was not reported.  The outcome of the events, arm started to hurt, arm tender to the touch, site a little bit raised, arm started getting itchy, arm still hot, rash on injection site and not feeling well was considered unknown.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site warmth
Clinical narrative: Not feeling well; Arm started to hurt/arm tender to the touch; Site a little bit raised; Arm started getting itchy; Arm still hot, it was hot to touch; Rash on the injection site; A spontaneous report was received from a consumer concerning a 70-year old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced arm started to hurt, arm tender to the touch (vaccination site pain), site a little bit raised (vaccination site swelling), arm started getting itchy (vaccination site pruritus), arm still hot (vaccination site warmth), rash on injection site (vaccination site rash) and not feeling well (malaise).  The patient's medical history was not provided. Concomitant medications were omeprazole, levothyroxine, lovastatin, carvedilol and aspirin.  On 9 Feb 2021, the patient received their first of two planned doses of mRNA-1273 (Batch number: unknown) for the prophylaxis of COVID-19 infection.  Patient received the vaccine on 09 Feb 2021 and her arm started to hurt was a little bit raised and tender to the touch. Later that night it started to get itchy. Patient stated arm was hot and tender.  Treatment information mentioned says took Tylenol PM and Benadryl. Lab tests not provided.  Action taken with response to mRNA-1273 was not reported.  The outcome of the events, arm started to hurt, arm tender to the touch, site a little bit raised, arm started getting itchy, arm still hot, rash on injection site and not feeling well was considered unknown.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Heavy menstrual bleeding, Hyperhidrosis, Myalgia
Clinical narrative: Bleeding more heavily; Sweating; Fever (103°F); Chills; Body aches; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of MENORRHAGIA (Bleeding more heavily), HYPERHIDROSIS (Sweating), PYREXIA (Fever (103°F)), CHILLS (Chills) and MYALGIA (Body aches) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012A21A and 007M20A) for COVID-19 vaccination.     Concomitant products included VITAMINS NOS for an unknown indication.   On 31-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 27-Feb-2021, the patient experienced HYPERHIDROSIS (Sweating), PYREXIA (Fever (103°F)), CHILLS (Chills) and MYALGIA (Body aches). On 28-Feb-2021, the patient experienced MENORRHAGIA (Bleeding more heavily). On 28-Feb-2021, HYPERHIDROSIS (Sweating), PYREXIA (Fever (103°F)), CHILLS (Chills) and MYALGIA (Body aches) had resolved. At the time of the report, MENORRHAGIA (Bleeding more heavily) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 27-Feb-2021, Body temperature: 103 (High) 103.         The patient's period is very regular and it had ended the week before vaccination. She consulted her physician who did not know what could be causing this.   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 30-Mar-2021: No new information. On 13-Apr-2021: No new information. Reporter declined further follow-up.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Bleeding more heavily; Sweating; Fever (103°F); Chills; Body aches; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of MENORRHAGIA (Bleeding more heavily), HYPERHIDROSIS (Sweating), PYREXIA (Fever (103°F)), CHILLS (Chills) and MYALGIA (Body aches) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012A21A and 007M20A) for COVID-19 vaccination.     Concomitant products included VITAMINS NOS for an unknown indication.   On 31-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 27-Feb-2021, the patient experienced HYPERHIDROSIS (Sweating), PYREXIA (Fever (103°F)), CHILLS (Chills) and MYALGIA (Body aches). On 28-Feb-2021, the patient experienced MENORRHAGIA (Bleeding more heavily). On 28-Feb-2021, HYPERHIDROSIS (Sweating), PYREXIA (Fever (103°F)), CHILLS (Chills) and MYALGIA (Body aches) had resolved. At the time of the report, MENORRHAGIA (Bleeding more heavily) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 27-Feb-2021, Body temperature: 103 (High) 103.         The patient's period is very regular and it had ended the week before vaccination. She consulted her physician who did not know what could be causing this.   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 30-Mar-2021: No new information. On 13-Apr-2021: No new information. Reporter declined further follow-up.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Pain in extremity, Paraesthesia oral
Clinical narrative: Tingling in mouth and chin; Headache; Sore Arm; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA ORAL (Tingling in mouth and chin), PAIN IN EXTREMITY (Sore Arm) and HEADACHE (Headache) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 050M20A) for COVID-19 vaccination.     Concurrent medical conditions included Allergy to antibiotic.    On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, the patient experienced PAIN IN EXTREMITY (Sore Arm). On 11-Feb-2021, the patient experienced PARAESTHESIA ORAL (Tingling in mouth and chin) and HEADACHE (Headache). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL A) at a dose of unknown. At the time of the report, PARAESTHESIA ORAL (Tingling in mouth and chin), PAIN IN EXTREMITY (Sore Arm) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Pruritus, Rash
Clinical narrative: rash, itchy and red in her back; rash, itchy and red in her back; rash, itchy and red in her back .; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (rash, itchy and red in her back), ERYTHEMA (rash, itchy and red in her back) and RASH (rash, itchy and red in her back .) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PRURITUS (rash, itchy and red in her back), ERYTHEMA (rash, itchy and red in her back) and RASH (rash, itchy and red in her back .). At the time of the report, PRURITUS (rash, itchy and red in her back), ERYTHEMA (rash, itchy and red in her back) and RASH (rash, itchy and red in her back .) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) and mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medications were provided No Treatment information provided
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Body temperature, Chills, Cold sweat, Diarrhoea
Clinical narrative: cold sweats; diarrhea; feel very weak; fever; nauseous; Chills; headache; This spontaneous case was reported by a consumer and describes the occurrence of COLD SWEAT (cold sweats), DIARRHOEA (diarrhea), ASTHENIA (feel very weak), PYREXIA (fever) and NAUSEA (nauseous) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included SARS-CoV-2 infection in October 2020.    On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, the patient experienced HEADACHE (headache). On 25-Feb-2021, the patient experienced COLD SWEAT (cold sweats), DIARRHOEA (diarrhea), ASTHENIA (feel very weak), PYREXIA (fever), NAUSEA (nauseous) and CHILLS (Chills). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and IBUPROFEN (ADVIL 12 HOUR) at an unspecified dose and frequency. On 27-Feb-2021, COLD SWEAT (cold sweats), DIARRHOEA (diarrhea), ASTHENIA (feel very weak), PYREXIA (fever), NAUSEA (nauseous), CHILLS (Chills) and HEADACHE (headache) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 25-Feb-2021, Body temperature: 100f (Inconclusive) fever of 100F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medications were provided
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Nausea, Pyrexia
Clinical narrative: cold sweats; diarrhea; feel very weak; fever; nauseous; Chills; headache; This spontaneous case was reported by a consumer and describes the occurrence of COLD SWEAT (cold sweats), DIARRHOEA (diarrhea), ASTHENIA (feel very weak), PYREXIA (fever) and NAUSEA (nauseous) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included SARS-CoV-2 infection in October 2020.    On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, the patient experienced HEADACHE (headache). On 25-Feb-2021, the patient experienced COLD SWEAT (cold sweats), DIARRHOEA (diarrhea), ASTHENIA (feel very weak), PYREXIA (fever), NAUSEA (nauseous) and CHILLS (Chills). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and IBUPROFEN (ADVIL 12 HOUR) at an unspecified dose and frequency. On 27-Feb-2021, COLD SWEAT (cold sweats), DIARRHOEA (diarrhea), ASTHENIA (feel very weak), PYREXIA (fever), NAUSEA (nauseous), CHILLS (Chills) and HEADACHE (headache) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 25-Feb-2021, Body temperature: 100f (Inconclusive) fever of 100F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medications were provided
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Chills, Fatigue
Clinical narrative: chills; felt tired; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills) and FATIGUE (felt tired) in an 82-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No past medical history was reported.     In January 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced CHILLS (chills) and FATIGUE (felt tired). At the time of the report, CHILLS (chills) and FATIGUE (felt tired) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 99 High.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient mentioned that her husband also has the antibodies and took first dose of vaccine. No treatment information was provided. No concomitant product was reported.
Sex: F
Vaccine: COVID19
Symptoms: Chest pain, Chills, Fatigue
Clinical narrative: Chest pain; Chills; Fatigue; A spontaneous report was received from a consumer concerning a female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced chills, fatigue and chest pain.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 10 Feb 2021, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: Unknown) through unknown route for prophylaxis of COVID-19 infection.  On 10 Feb 2021, the patient experienced fatigue and chills. On 11 Feb 2021, the patient experienced chest pain.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of events was unknown.
Sex: M
Vaccine: COVID19
Symptoms: Chills, Fatigue, Malaise, Pain
Clinical narrative: Feeling sick; Chilled; Has pain; Is in bed (fatigued); A spontaneous report was received from a consumer concerning a unknown age, male patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events feeling sick, chilled, has pain and is in bed(fatigued).  The patient's medical history was not provided. Concomitant medications reported were meloxicam 15 mg daily.   On an unknown date, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: unknown) unknown route for prophylaxis of COVID-19 infection.  On 09 Feb 2021, approximately 2 days prior to the onset of the events the patient received second of two planned doses of mRNA-1273 (lot/batch: unknown) intramuscularly in the right arm for prophylaxis of COVID-19 infection.  On 10 Feb 2021, the patient experienced the event(s) feeling sick, chilled, has pain and is in bed.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of event(s), feeling sick, chilled, has pain and is in bed(fatigued) was unknown.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Headache, Pain in extremity
Clinical narrative: Headache; Pain Left Leg Severe; Pain Behind Knee; A spontaneous report was received from a consumer concerning a 64-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced pain left leg severe/pain in extremity, pain behind knee/arthralgia, headache.  The patient's medical history was not provided. Concomitant medications reported were Aspirin 81mg daily for drug use for unknown indication.  On 8 Feb 2021, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: 016N20A) intramuscularly for prophylaxis of COVID-19 infection.  On 8 Feb 2021, the patient experienced pain left leg severe/pain in extremity, pain behind knee/arthralgia, headache.  Treatment details included Tylenol.  Action taken with mRNA-1273 in response to the events was not reported.   on an unknown date the outcome of pain left leg severe/pain in extremity, pain behind knee/arthralgia, headache was unknown.
Sex: M
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Myalgia
Clinical narrative: chills; body aches; headache all day; Feeling very tired; A spontaneous  report  was received from a  consumer concerning an male patient who received Moderna's COVID-19 Vaccine (mRNA-1273) and    experienced Head ache, chills, fatigue, body aches.  The patient's medical history, was not provided by the reporter, included no known allergies,  Concomitant medications were not reported.  On Un known date the patient received their   second   of two planned doses of mRNA-1273 (lot number  Unknown)  for prophylaxis of COVID-19 infection.  On Unknown date  the patient experienced  events chills, body aches, head ache and fatigue.   Treatment information  provided was Advil and Dayquil.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of the events   Head ache and chills were Resolved. and Fatigue and body aches were not Resolved.
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Vaccination site erythema, Vaccination site pruritus
Clinical narrative: the site of injection was red and itchy; tired; the site of injection was red and itchy; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (the site of injection was red and itchy), FATIGUE (tired) and VACCINATION SITE PRURITUS (the site of injection was red and itchy) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, the patient experienced VACCINATION SITE ERYTHEMA (the site of injection was red and itchy), FATIGUE (tired) and VACCINATION SITE PRURITUS (the site of injection was red and itchy). At the time of the report, VACCINATION SITE ERYTHEMA (the site of injection was red and itchy), FATIGUE (tired) and VACCINATION SITE PRURITUS (the site of injection was red and itchy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.  No concomitant medications were reported. No treatment related information has been reported.       Reporter did not allow further contact
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain upper, Arthralgia, Diarrhoea, Disorientation, Nausea
Clinical narrative: Violent shakes; disoriented; skin was hot to touch; fever of 104; Sore shoulder; Nausea; Diarrhea; Frequent urination (7 times last night; Very bad stomach cramp; This spontaneous case was reported by a consumer and describes the occurrence of TREMOR (Violent shakes), POLLAKIURIA (Frequent urination (7 times last night), ABDOMINAL PAIN UPPER (Very bad stomach cramp), DISORIENTATION (disoriented) and DIARRHOEA (Diarrhea) in an 84-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, the patient experienced POLLAKIURIA (Frequent urination (7 times last night), ABDOMINAL PAIN UPPER (Very bad stomach cramp), DIARRHOEA (Diarrhea), ARTHRALGIA (Sore shoulder) and NAUSEA (Nausea). On an unknown date, the patient experienced TREMOR (Violent shakes), DISORIENTATION (disoriented), SKIN WARM (skin was hot to touch) and PYREXIA (fever of 104). On 26-Feb-2021, POLLAKIURIA (Frequent urination (7 times last night), ABDOMINAL PAIN UPPER (Very bad stomach cramp), DIARRHOEA (Diarrhea), ARTHRALGIA (Sore shoulder) and NAUSEA (Nausea) had resolved. At the time of the report, TREMOR (Violent shakes), DISORIENTATION (disoriented) and PYREXIA (fever of 104) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment medications included Anti-diarrheal drugs and Antacids. No concomitant medications were provided by reporter.   Most recent FOLLOW-UP information incorporated above includes: On 29-Apr-2021: :Details of AEs were updated and consumer agreed to fill out ADR form
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Pollakiuria, Pyrexia, Skin warm, Tremor
Clinical narrative: Violent shakes; disoriented; skin was hot to touch; fever of 104; Sore shoulder; Nausea; Diarrhea; Frequent urination (7 times last night; Very bad stomach cramp; This spontaneous case was reported by a consumer and describes the occurrence of TREMOR (Violent shakes), POLLAKIURIA (Frequent urination (7 times last night), ABDOMINAL PAIN UPPER (Very bad stomach cramp), DISORIENTATION (disoriented) and DIARRHOEA (Diarrhea) in an 84-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, the patient experienced POLLAKIURIA (Frequent urination (7 times last night), ABDOMINAL PAIN UPPER (Very bad stomach cramp), DIARRHOEA (Diarrhea), ARTHRALGIA (Sore shoulder) and NAUSEA (Nausea). On an unknown date, the patient experienced TREMOR (Violent shakes), DISORIENTATION (disoriented), SKIN WARM (skin was hot to touch) and PYREXIA (fever of 104). On 26-Feb-2021, POLLAKIURIA (Frequent urination (7 times last night), ABDOMINAL PAIN UPPER (Very bad stomach cramp), DIARRHOEA (Diarrhea), ARTHRALGIA (Sore shoulder) and NAUSEA (Nausea) had resolved. At the time of the report, TREMOR (Violent shakes), DISORIENTATION (disoriented) and PYREXIA (fever of 104) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment medications included Anti-diarrheal drugs and Antacids. No concomitant medications were provided by reporter.   Most recent FOLLOW-UP information incorporated above includes: On 29-Apr-2021: :Details of AEs were updated and consumer agreed to fill out ADR form
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Back pain, Fatigue, Headache, Hypoaesthesia, Injection site bruising
Clinical narrative: arm is bruised, black and blue in the injection site; pain is worse in sensitivity areas from surgery; headaches; fatigue; back pain; arm pain; numbness and tingling in hands and feet.; This spontaneous case was reported by a consumer and describes the occurrence of BACK PAIN (back pain), PAIN IN EXTREMITY (arm pain), HYPOAESTHESIA (numbness and tingling in hands and feet.), INJECTION SITE BRUISING (arm is bruised, black and blue in the injection site) and PAIN (pain is worse in sensitivity areas from surgery) in an 81-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013L20A and 015M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Orthopedic procedure (6 surgeries on 2020 but mostly orthopedic ones). Concomitant products included CIPROFLOXACIN, TRIAMTERENE, QUINAPRIL, ATENOLOL and ALFUZOSIN for an unknown indication.   On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 12-Feb-2021, the patient experienced BACK PAIN (back pain), PAIN IN EXTREMITY (arm pain), HYPOAESTHESIA (numbness and tingling in hands and feet.), PAIN (pain is worse in sensitivity areas from surgery), HEADACHE (headaches) and FATIGUE (fatigue). On an unknown date, the patient experienced INJECTION SITE BRUISING (arm is bruised, black and blue in the injection site). At the time of the report, BACK PAIN (back pain), PAIN IN EXTREMITY (arm pain), HYPOAESTHESIA (numbness and tingling in hands and feet.), INJECTION SITE BRUISING (arm is bruised, black and blue in the injection site), PAIN (pain is worse in sensitivity areas from surgery), HEADACHE (headaches) and FATIGUE (fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Pain, Pain in extremity
Clinical narrative: arm is bruised, black and blue in the injection site; pain is worse in sensitivity areas from surgery; headaches; fatigue; back pain; arm pain; numbness and tingling in hands and feet.; This spontaneous case was reported by a consumer and describes the occurrence of BACK PAIN (back pain), PAIN IN EXTREMITY (arm pain), HYPOAESTHESIA (numbness and tingling in hands and feet.), INJECTION SITE BRUISING (arm is bruised, black and blue in the injection site) and PAIN (pain is worse in sensitivity areas from surgery) in an 81-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013L20A and 015M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Orthopedic procedure (6 surgeries on 2020 but mostly orthopedic ones). Concomitant products included CIPROFLOXACIN, TRIAMTERENE, QUINAPRIL, ATENOLOL and ALFUZOSIN for an unknown indication.   On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 12-Feb-2021, the patient experienced BACK PAIN (back pain), PAIN IN EXTREMITY (arm pain), HYPOAESTHESIA (numbness and tingling in hands and feet.), PAIN (pain is worse in sensitivity areas from surgery), HEADACHE (headaches) and FATIGUE (fatigue). On an unknown date, the patient experienced INJECTION SITE BRUISING (arm is bruised, black and blue in the injection site). At the time of the report, BACK PAIN (back pain), PAIN IN EXTREMITY (arm pain), HYPOAESTHESIA (numbness and tingling in hands and feet.), INJECTION SITE BRUISING (arm is bruised, black and blue in the injection site), PAIN (pain is worse in sensitivity areas from surgery), HEADACHE (headaches) and FATIGUE (fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Headache, Peripheral swelling
Clinical narrative: left leg is swollen; headache; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (left leg is swollen) and HEADACHE (headache) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     Concurrent medical conditions included Lymphedema (lymphedema class 2) and Thyroid disorder. Concomitant products included DULOXETINE and LEVOTHYROXINE, LIOTHYRONINE (NP THYROID) for an unknown indication.    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In February 2021, the patient experienced PERIPHERAL SWELLING (left leg is swollen) and HEADACHE (headache). The patient was treated with THYROID (NATURE THROID) at a dose of used for years and went off for 6 days and IBUPROFEN at an unspecified dose and frequency. At the time of the report, PERIPHERAL SWELLING (left leg is swollen) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication included: T4 and T3 compounded.  The patient started experiencing headache about a week and half ago. She had taken Ibuprofen. The headache usually wakes up in the morning or comes later in the day, and she never get headaches. Patient also states she has lymphedema class 2 and forgot to put it down when she received the first dose, her left leg is swollen but she has gained some weight from her thyroid issues. She wants to know if there is any correlation with lymphedema and the vaccine.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Antibody test, Dizziness, Nausea, Pain in extremity, Pyrexia
Clinical narrative: she was real "swimmy" headed, like a fog; sinus infection with fever; sinus infection with fever; arm sore; felt nauseated; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm sore), DIZZINESS (she was real "swimmy" headed, like a fog), SINUSITIS (sinus infection with fever), NAUSEA (felt nauseated) and PYREXIA (sinus infection with fever) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Lot 013L20A) for COVID-19 vaccination.     Concomitant products included MESALAMINE, HYDROCHLOROTHIAZIDE, TELMISARTAN (TELMISARTAN HCTZ), GABAPENTIN, VITAMIN D2, CALCIUM, CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000), FISH OIL, MONASCUS PURPUREUS, NICOTINAMIDE, PHYTOSTEROLS NOS (RED YEAST RICE WITH PLANT STEROLS) and CENTRUM SILVER +50 for an unknown indication.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Jan-2021, the patient experienced PAIN IN EXTREMITY (arm sore) and NAUSEA (felt nauseated). On an unknown date, the patient experienced DIZZINESS (she was real "swimmy" headed, like a fog), SINUSITIS (sinus infection with fever) and PYREXIA (sinus infection with fever). On 27-Jan-2021, NAUSEA (felt nauseated) had resolved. On 29-Jan-2021, PAIN IN EXTREMITY (arm sore) had resolved. At the time of the report, DIZZINESS (she was real "swimmy" headed, like a fog), SINUSITIS (sinus infection with fever) and PYREXIA (sinus infection with fever) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Antibody test: 7.8 or 7/8 (Inconclusive) 7.8, or 7/8?.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No treatment information provided.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Sinusitis
Clinical narrative: she was real "swimmy" headed, like a fog; sinus infection with fever; sinus infection with fever; arm sore; felt nauseated; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm sore), DIZZINESS (she was real "swimmy" headed, like a fog), SINUSITIS (sinus infection with fever), NAUSEA (felt nauseated) and PYREXIA (sinus infection with fever) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Lot 013L20A) for COVID-19 vaccination.     Concomitant products included MESALAMINE, HYDROCHLOROTHIAZIDE, TELMISARTAN (TELMISARTAN HCTZ), GABAPENTIN, VITAMIN D2, CALCIUM, CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000), FISH OIL, MONASCUS PURPUREUS, NICOTINAMIDE, PHYTOSTEROLS NOS (RED YEAST RICE WITH PLANT STEROLS) and CENTRUM SILVER +50 for an unknown indication.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Jan-2021, the patient experienced PAIN IN EXTREMITY (arm sore) and NAUSEA (felt nauseated). On an unknown date, the patient experienced DIZZINESS (she was real "swimmy" headed, like a fog), SINUSITIS (sinus infection with fever) and PYREXIA (sinus infection with fever). On 27-Jan-2021, NAUSEA (felt nauseated) had resolved. On 29-Jan-2021, PAIN IN EXTREMITY (arm sore) had resolved. At the time of the report, DIZZINESS (she was real "swimmy" headed, like a fog), SINUSITIS (sinus infection with fever) and PYREXIA (sinus infection with fever) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Antibody test: 7.8 or 7/8 (Inconclusive) 7.8, or 7/8?.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No treatment information provided.
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Chest pain, Fatigue, Headache, Tinnitus
Clinical narrative: tinnitus; chest pain; weak; headache; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of TINNITUS (tinnitus), CHEST PAIN (chest pain), ASTHENIA (weak), HEADACHE (headache) and FATIGUE (fatigue) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced TINNITUS (tinnitus), CHEST PAIN (chest pain), ASTHENIA (weak), HEADACHE (headache) and FATIGUE (fatigue). At the time of the report, TINNITUS (tinnitus), CHEST PAIN (chest pain), ASTHENIA (weak), HEADACHE (headache) and FATIGUE (fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided. No treatment medications were provided.
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Bedridden, Chills, Fatigue, Illness
Clinical narrative: still in bed; She couldn't eat, couldn't get up, couldn't do anything; very very sick; chills; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (very very sick), BEDRIDDEN (still in bed), FATIGUE (She couldn't eat, couldn't get up, couldn't do anything) and CHILLS (chills) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. D29L20A and 001A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Feb-2021, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 23-Feb-2021, the patient experienced CHILLS (chills). On 24-Feb-2021, the patient experienced ILLNESS (very very sick). On 01-Mar-2021, the patient experienced FATIGUE (She couldn't eat, couldn't get up, couldn't do anything). On an unknown date, the patient experienced BEDRIDDEN (still in bed). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at a dose of UNK, q4h. At the time of the report, ILLNESS (very very sick), BEDRIDDEN (still in bed), FATIGUE (She couldn't eat, couldn't get up, couldn't do anything) and CHILLS (chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (sore arm). At the time of the report, PAIN IN EXTREMITY (sore arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No concomitant medications were provided. No treatment medications were provided.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Pain, Pyrexia
Clinical narrative: body ache; having fever of 100 degree temperature; chills; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (body ache), PYREXIA (having fever of 100 degree temperature) and CHILLS (chills) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Feb-2021, the patient experienced PAIN (body ache), PYREXIA (having fever of 100 degree temperature) and CHILLS (chills). The patient was treated with Ibuprofen for Adverse event, at an unspecified dose and frequency. At the time of the report, PAIN (body ache), PYREXIA (having fever of 100 degree temperature) and CHILLS (chills) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Pyrexia: 100 °F (High) Fever.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided.
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Urticaria
Clinical narrative: breakout of hives throughout body, Welts; itching; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (breakout of hives throughout body, Welts) and PRURITUS (itching) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced URTICARIA (breakout of hives throughout body, Welts) and PRURITUS (itching). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Adverse event, at an unspecified dose and frequency. At the time of the report, URTICARIA (breakout of hives throughout body, Welts) and PRURITUS (itching) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Chills, Pyrexia, Urticaria
Clinical narrative: hives; weakness; fever; chills; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (hives), ASTHENIA (weakness), PYREXIA (fever) and CHILLS (chills) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028120a) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced URTICARIA (hives), ASTHENIA (weakness), PYREXIA (fever) and CHILLS (chills). At the time of the report, URTICARIA (hives), ASTHENIA (weakness), PYREXIA (fever) and CHILLS (chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided. No treatment medications were provided.
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site induration, Vaccination site rash
Clinical narrative: Hardness - Near Injection site; Rash - Near Injection Site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE INDURATION (Hardness - Near Injection site) and VACCINATION SITE RASH (Rash - Near Injection Site) in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012M20A and 013A21A) for COVID-19 vaccination.  No Medical History information was reported.  On 27-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to dosage form. On 27-Feb-2021, the patient experienced VACCINATION SITE INDURATION (Hardness - Near Injection site) and VACCINATION SITE RASH (Rash - Near Injection Site). At the time of the report, VACCINATION SITE INDURATION (Hardness - Near Injection site) and VACCINATION SITE RASH (Rash - Near Injection Site) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No Concomitant medications were  reported. Treatment for the events not provided.   Action taken with mRNA-1273 in response to the events was not applicable.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Fatigue, Muscle spasms, Vaccination site discolouration
Clinical narrative: Cramps in legs; Fatigue; Chills; Red injection site with a white spot in the middle; Swollen injection site; Red injection site with a white spot in the middle; Joint pain; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE DISCOLOURATION (Red injection site with a white spot in the middle), MUSCLE SPASMS (Cramps in legs), VACCINATION SITE SWELLING (Swollen injection site), VACCINATION SITE ERYTHEMA (Red injection site with a white spot in the middle) and ARTHRALGIA (Joint pain) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Feb-2021, the patient experienced VACCINATION SITE DISCOLOURATION (Red injection site with a white spot in the middle), VACCINATION SITE SWELLING (Swollen injection site), VACCINATION SITE ERYTHEMA (Red injection site with a white spot in the middle) and ARTHRALGIA (Joint pain). On 23-Feb-2021, the patient experienced CHILLS (Chills). On 27-Feb-2021, the patient experienced FATIGUE (Fatigue). On an unknown date, the patient experienced MUSCLE SPASMS (Cramps in legs). At the time of the report, VACCINATION SITE DISCOLOURATION (Red injection site with a white spot in the middle), MUSCLE SPASMS (Cramps in legs), VACCINATION SITE SWELLING (Swollen injection site), VACCINATION SITE ERYTHEMA (Red injection site with a white spot in the middle), CHILLS (Chills) and FATIGUE (Fatigue) outcome was unknown and ARTHRALGIA (Joint pain) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided. No treatment medications were provided.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site swelling
Clinical narrative: Cramps in legs; Fatigue; Chills; Red injection site with a white spot in the middle; Swollen injection site; Red injection site with a white spot in the middle; Joint pain; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE DISCOLOURATION (Red injection site with a white spot in the middle), MUSCLE SPASMS (Cramps in legs), VACCINATION SITE SWELLING (Swollen injection site), VACCINATION SITE ERYTHEMA (Red injection site with a white spot in the middle) and ARTHRALGIA (Joint pain) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Feb-2021, the patient experienced VACCINATION SITE DISCOLOURATION (Red injection site with a white spot in the middle), VACCINATION SITE SWELLING (Swollen injection site), VACCINATION SITE ERYTHEMA (Red injection site with a white spot in the middle) and ARTHRALGIA (Joint pain). On 23-Feb-2021, the patient experienced CHILLS (Chills). On 27-Feb-2021, the patient experienced FATIGUE (Fatigue). On an unknown date, the patient experienced MUSCLE SPASMS (Cramps in legs). At the time of the report, VACCINATION SITE DISCOLOURATION (Red injection site with a white spot in the middle), MUSCLE SPASMS (Cramps in legs), VACCINATION SITE SWELLING (Swollen injection site), VACCINATION SITE ERYTHEMA (Red injection site with a white spot in the middle), CHILLS (Chills) and FATIGUE (Fatigue) outcome was unknown and ARTHRALGIA (Joint pain) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided. No treatment medications were provided.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Skin warm
Clinical narrative: slight headache; warmth on the back of both arms and on their trunk and chest, it was a little itchy. Every day feels; This spontaneous case was reported by a physician and describes the occurrence of SKIN WARM (warmth on the back of both arms and on their trunk and chest, it was a little itchy. Every day feels) and HEADACHE (slight headache) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID), OMEPRAZOLE (PROTONIX [OMEPRAZOLE]), MONTELUKAST SODIUM (SINGULAIR), ERGOCALCIFEROL, RETINOL PALMITATE (VITAMINS A & D) and METOPROLOL SUCCINATE (TOPROL) for an unknown indication.    On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Feb-2021, the patient experienced SKIN WARM (warmth on the back of both arms and on their trunk and chest, it was a little itchy. Every day feels). On an unknown date, the patient experienced HEADACHE (slight headache). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, SKIN WARM (warmth on the back of both arms and on their trunk and chest, it was a little itchy. Every day feels) and HEADACHE (slight headache) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.